It was announced today that Jefferson Health, Penn Medicine and Temple Health have been selected as the 2026 Clinical Care ...

Although three-fourths (76%) of breast cancer patients are exposed to cancer misinformation, perpetuating fear in 38%, it did ...

Americans are turning to artificial intelligence (AI) to help navigate the challenges of the U.S. healthcare system, according to the January 2026 report “AI as a Healthcare Ally: How Americans are ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated with glufosfamide. The study revealed four patient clusters, with one ...

In 2026, AI will continue threading itself into behavioral health, and the bar will rise sharply for what counts as ...

Medicaid expansion under the ACA improved long-term survival for younger adults with operable lung cancer, despite no earlier ...

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...

Patients will demand transparency and value, expecting personalized, data-rich experiences with clear prices and quality ...

The oral versions may set records in 2026, and glucagon-like peptide 1 (GLP-1) drugs will pick up even more momentum as ...

By 2027, most private insurance plans must cover HPV screening and follow-up testing without cost-sharing, reducing financial ...

The CDC reduced required childhood vaccines from 17 to 11, influenced by Denmark's vaccine policy, sparking debate over public health implications.